Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionHgk Asset Management Inc
Latest Disclosed Ownership138,879 shares
Latest Disclosed Value $ 8,423,011
Hgk Asset Management Inc reports 17.71% decrease in ownership of BRM / Bristol-Myers Squibb Company

On April 27, 2026 - Hgk Asset Management Inc filed a 13F-HR form disclosing ownership of 138,879 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $7,280,037 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 27, 2026 disclosing 168,767 shares of Bristol-Myers Squibb Company. This represents a change in shares of -17.71% during the quarter. The current value of the position is $6,587,031 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F Bristol-Myers Squibb COM 110122108 138,879 -29,888 -17.71 8,423 -7.47 1.2310
2026-01-27 2025-12-31 13F Bristol-Myers Squibb COM 110122108 168,767 23,799 16.42 9,103 39.23 1.3488
2025-10-30 2025-09-30 13F Bristol-Myers Squibb COM 110122108 144,968 13,394 10.18 6,538 7.36 1.0583
2025-07-21 2025-06-30 13F Bristol-Myers Squibb COM 110122108 131,574 17,191 15.03 6,091 -12.70 1.0421
2025-04-28 2025-03-31 13F Bristol-Myers Squibb COM 110122108 114,383 -13,804 -10.77 6,976 -3.78 1.4184
2025-02-03 2024-12-31 13F Bristol-Myers Squibb COM 110122108 128,187 -9,511 -6.91 7,250 1.77 1.3368
2024-10-31 2024-09-30 13F Bristol-Myers Squibb COM 110122108 137,698 6,676 5.10 7,124 30.93 1.3208
2024-08-06 2024-06-30 13F Bristol-Myers Squibb COM 110122108 131,022 6,757 5.44 5,441 -19.25 1.0512
2024-05-13 2024-03-31 13F Bristol-Myers Squibb COM 110122108 124,265 8,469 7.31 6,739 13.42 1.3156
2024-02-13 2023-12-31 13F Bristol-Myers Squibb COM 110122108 115,796 15,983 16.01 5,941 118,720.00 1.3799
2023-10-20 2023-09-30 13F Bristol-Myers Squibb Common Stock 110122108 99,813 8,229 8.99 6 0.00 1.8925
2023-08-02 2023-06-30 13F Bristol-Myers Squibb Common Stock 110122108 91,584 3,322 3.76 6 -16.67 1.8627
2023-04-28 2023-03-31 13F Bristol-Myers Squib Common Stock 110122108 88,262 15,120 20.67 6 20.00 1.8998
2023-02-14 2022-12-31 13F Bristol-Myers Squib Common Stock 110122108 73,142 340 0.47 5 -99.90 1.7963
2022-10-18 2022-09-30 13F Bristol-Myers Squib Common Stock 110122108 72,802 -7,674 -9.54 5,175 -16.49 1.9263
2022-07-29 2022-06-30 13F Bristol-Myers Squib Common Stock 110122108 80,476 -11,447 -12.45 6,197 -7.69 2.2587
2022-05-04 2022-03-31 13F Bristol-Myers Squib Common Stock 110122108 91,923 -13,245 -12.59 6,713 2.38 2.1142
2022-02-01 2021-12-31 13F Bristol-Myers Squib Common Stock 110122108 105,168 11,714 12.53 6,557 18.57 2.0312
2021-10-28 2021-09-30 13F Bristol-Myers Squib Common Stock 110122108 93,454 6,464 7.43 5,530 -4.87 1.8152
2021-07-30 2021-06-30 13F Bristol-Myers Squib Common Stock 110122108 86,990 4,192 5.06 5,813 11.21 1.8508
2021-04-15 2021-03-31 13F Bristol-Myers Squib Common Stock 110122108 82,798 5,275 6.80 5,227 8.69 1.7281
2021-01-08 2020-12-31 13F Bristol-Myers Squib Common Stock 110122108 77,523 5,642 7.85 4,809 10.96 1.7139
2020-11-05 2020-09-30 13F Bristol-Myers Squib Common Stock 110122108 71,881 -26,353 -26.83 4,334 -24.97 1.7400
2020-08-10 2020-06-30 13F Bristol-Myers Squib Common Stock 110122108 98,234 -24,875 -20.21 5,776 -15.83 1.8619
2020-04-28 2020-03-31 13F Bristol-Myers Squib Common Stock 110122108 123,109 -1,449 -1.16 6,862 -14.17 2.6057
2020-01-27 2019-12-31 13F Bristol-Myers Squib Common Stock 110122108 124,558 -21,951 -14.98 7,995 7.62 2.1028
2019-11-13 2019-09-30 13F/A-1 Bristol-Myers Squib Common Stock 110122108 146,509 -500 -0.34 7,429 11.43 2.0853
2019-10-24 2019-09-30 13F Bristol-Myers Squib Common Stock 110122108 128,767 -18,242 7,994 2,268,168.1861
2019-07-23 2019-06-30 13F Bristol-Myers Squib Common Stock 110122108 147,009 8,058 5.80 6,667 0.57 1.9375
2019-05-07 2019-03-31 13F Bristol-Myers Squib Common Stock 110122108 138,951 -7,641 -5.21 6,629 -13.01 1.9974
2019-01-31 2018-12-31 13F Bristol-Myers Squib Common Stock 110122108 146,592 -61,840 -29.67 7,620 -41.11 2.3587
2018-10-29 2018-09-30 13F Bristol-Myers Squib Common Stock 110122108 208,432 -16,579 -7.37 12,939 3.91 2.3020
2018-08-08 2018-06-30 13F Bristol-Myers Squib Common Stock 110122108 225,011 148 0.07 12,452 -12.45 2.3221
2018-05-08 2018-03-31 13F Bristol-Myers Squib Common Stock 110122108 224,863 -33,054 -12.82 14,223 -10.01 2.1546
2018-02-08 2017-12-31 13F Bristol-Myers Squib Common Stock 110122108 257,917 -7,324 -2.76 15,805 -6.51 2.1808
2017-11-13 2017-09-30 13F Bristol-Myers Squib Common Stock 110122108 265,241 -54,074 -16.93 16,906 -4.98 2.4022
2017-08-10 2017-06-30 13F Bristol-Myers Squib Common Stock 110122108 319,315 10,490 3.40 17,792 5.94 2.4995
2017-05-04 2017-03-31 13F Bristol-Myers Squib Common Stock 110122108 308,825 53,221 20.82 16,794 12.43 2.2353
2017-02-14 2016-12-31 13F Bristol-Myers Squib Common Stock 110122108 255,604 27,444 12.03 14,937 21.42 2.0387
2016-11-08 2016-09-30 13F Bristol-Myers Squib Common Stock 110122108 228,160 215,865 1,755.71 12,302 1,260.84 1.8392
2016-08-04 2016-06-30 13F Bristol-Myers Squib Common Stock 110122108 12,295 -105 -0.85 904 14.14 0.1349
2016-04-29 2016-03-31 13F Bristol-Myers Squib COM 110122108 12,400 -100 -0.80 792 -7.91 0.0783
2016-02-01 2015-12-31 13F Bristol-Myers Squib Common Stock 110122108 12,500 0 0.00 860 16.22 0.0833
2015-11-10 2015-09-30 13F Bristol-Myers Squib Common Stock 110122108 12,500 700 5.93 740 -5.73 0.0399
2015-08-05 2015-06-30 13F Bristol-Myers Squib Common Stock 110122108 11,800 -1,060 -8.24 785 -5.31 0.0330
2015-04-27 2015-03-31 13F Bristol-Myers Squib Common Stock 110122108 12,860 12,860 0.00 829 0.0342
2015-02-02 2014-12-31 13F Bristol-Myers Squib Common Stock 110122108 0 -13,060 -100.00 0 -100.00
2014-11-04 2014-09-30 13F Bristol-Myers Squib Common Stock 110122108 13,060 0 0.00 668 5.36 0.0245
2014-08-08 2014-06-30 13F Bristol-Myers Squib Common Stock 110122108 13,060 10 0.08 634 -6.49 0.0225
2014-05-01 2014-03-31 13F Bristol-Myers Squib Common Stock 110122108 13,050 0 0.00 678 -2.31 0.0257
2014-01-29 2013-12-31 13F Bristol-Myers Squib COM 110122108 13,050 -150 -1.14 694 13.58 0.0267
2013-10-31 2013-09-30 13F Bristol-Myers Squib COM 110122108 13,200 -250 -1.86 611 1.66 0.0253
2013-08-07 2013-06-30 13F BRISTOL-MYERS SQUIB COM 110122108 13,450 13,450 601 0.0238
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.